Form 8-K · Current report
News Corp 8-K, filed Sep 17, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000203
Summary
News Corp reported daily buy-back activity to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes up to US$1 billion of its Nasdaq-listed Class A and Class B common stock. The company bought back 54,641 shares for about US$1.66 million on 16 September 2026, bringing the program's cumulative purchases to roughly US$480.9 million.
Key points
- News Corp repurchased 54,641 shares on 16 September 2026 at prices between US$29.96 and US$30.64.
- Cumulative buy-backs under the 2025 Repurchase Program total 12,012,660 shares for about US$313.2 million in consideration.
- The program, authorized as of 15 July 2025, covers up to US$1 billion in aggregate of Class A and Class B common stock, with repurchases made in the open market or otherwise.
- Goldman Sachs & Co. LLC is named as broker for the buy-back, and no ASX-listed CDIs will be repurchased.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.